SPATA16 activators represent a class of chemical compounds specifically designed to enhance the activity of the SPATA16 protein, which is implicated in spermatogenesis and is critical for male fertility. The development of these activators is driven by the understanding that SPATA16 plays a significant role in the proper formation of spermatozoa, with mutations or deficiencies in this protein being linked to male infertility. Enhancing SPATA16 activity through chemical activators can potentially ameliorate conditions associated with defective spermatogenesis, offering a novel approach to addressing certain forms of male infertility. The initial phase in the discovery of SPATA16 activators typically involves the use of high-throughput screening (HTS) techniques, aimed at identifying compounds that can increase the activity or expression of SPATA16. This screening process seeks to uncover molecules that can either bind directly to SPATA16, altering its conformation in a way that enhances its activity, or modulate the cellular signaling pathways that lead to its upregulation. The goal is to isolate compounds that specifically target SPATA16, providing a means to directly influence spermatogenesis at a molecular level.
Following the identification of potential activators through HTS, structure-activity relationship (SAR) studies are employed to refine these compounds, optimizing their specificity and potency. SAR studies involve systematic modifications to the chemical structures of the identified compounds, assessing how these changes affect their ability to enhance SPATA16 activity. This iterative process is crucial for improving the interaction between the activators and SPATA16, ensuring that the compounds are effective in specifically targeting SPATA16 with minimal off-target effects. Techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are instrumental in this phase, providing detailed insights into the molecular interactions at play, which is essential for the rational design of more effective SPATA16 activators. Additionally, cellular and in vivo assays are utilized to evaluate the functional impact of these activators within a biological context, confirming their ability to stimulate SPATA16 activity and promote spermatogenesis. Through a comprehensive approach that combines targeted chemical synthesis, detailed structural analysis, and functional validation, SPATA16 activators are developed with the aim of modulating the activity of SPATA16 precisely.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Involved in spermatogenesis; could indirectly influence SPATA16 function. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Vital for sperm formation and function, could influence SPATA16 activity. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Although primarily a female hormone, it plays a role in male reproductive health, potentially affecting SPATA16. | ||||||
Vitamin A | 68-26-8 | sc-280187 sc-280187A | 1 g 10 g | $385.00 $2654.00 | ||
Essential for normal spermatogenesis, might indirectly influence SPATA16. | ||||||
(+)-α-Tocopherol | 59-02-9 | sc-214454 sc-214454A sc-214454B sc-214454C | 10 g 25 g 100 g 1 kg | $43.00 $62.00 $141.00 $430.00 | ||
An antioxidant, plays a role in reproductive health and could affect SPATA16. | ||||||
Selenium | 7782-49-2 | sc-250973 | 50 g | $62.00 | 1 | |
Important for testicular development and spermatogenesis, potentially influencing SPATA16. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog, can influence signaling pathways in spermatogenesis, potentially impacting SPATA16. | ||||||